The Division of Cancer Biology studies the complex interplay of genes, proteins and biological processes that drive the development and growth of cancers. Understanding the many different biological ...

We are currently advertising one fully-funded PhD project and the application deadline is Sunday 1st September 2024. Below you will find a link to further information about our application process, ...

The Generations Study is a longitudinal cohort study that collects extensive high-quality data to study the continuum of breast cancer.

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found.

Yvonne Diaz, 55, was diagnosed with stage 4 ALK-positive lung cancer in August 2021. She works in Communications and lives in Holland Park, London with her husband and twin sons, aged 17.

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

We have uncovered more cancer predisposition genes than any other organisation, and we host some of the world’s largest epidemiological studies of the environmental and lifestyle factors that ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

The National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research is the only BRC focused ...

Abiraterone is one of the ICR’s biggest success stories – the first treatment shown to be effective in men with advanced prostate cancer. In 2012 it was made available on the NHS, at a stroke ...

Dr George’s group is focused on understanding the underlying biology of difficult to treat neuroblastoma and identifying new treatments to target the underlying drivers of aggressive disease. Dr Sally ...